Literature DB >> 21448757

Aggregation stability of a monoclonal antibody during downstream processing.

Paolo Arosio1, Giuliano Barolo, Thomas Müller-Späth, Hua Wu, Massimo Morbidelli.   

Abstract

PURPOSE: To study the effect of several operative parameters, particularly pH and salt concentration, on the stability and aggregation kinetics of IgG solutions under the conditions typically encountered in downstream processing.
METHODS: The time evolution of the aggregates is analyzed by a combination of dynamic light scattering, size exclusion chromatography (SEC) and field flow fractionation (FFF). Secondary structure changes are monitored by circular dichroism.
RESULTS: For the given antibody, it is found that at pH lower than 4.0 addition of salt induces a reversible aggregation to oligomers accompanied by an increase in the content of the β-sheet structure. The aggregation rate increases monotonically with the salt concentration. Both the SEC and FFF techniques are successfully applied to obtain the oligomer distributions, and their results are consistent. The modified Lumry-Eyring kinetic model can well describe the time evolutions of the oligomers.
CONCLUSIONS: For the given antibody, low pH and presence of salt induce conformational changes that are responsible for the reversible aggregation, but in the investigated conditions only small soluble oligomers are formed and oligomer sizes larger than trimer are negligible. For this reason, no accompanied macroscopic changes can be observed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448757     DOI: 10.1007/s11095-011-0416-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

1.  Hydrostatic pressure rescues native protein from aggregates.

Authors:  D Foguel; C R Robinson; P C de Sousa; J L Silva; A S Robinson
Journal:  Biotechnol Bioeng       Date:  1999-06-05       Impact factor: 4.530

2.  The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein.

Authors:  A W Vermeer; W Norde
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

3.  Programmed cross flow asymmetrical flow field-flow fractionation for the size separation of pullulans and hydroxypropyl cellulose.

Authors:  Mats Leeman; Karl-Gustav Wahlund; Bengt Wittgren
Journal:  J Chromatogr A       Date:  2006-09-11       Impact factor: 4.759

4.  Shaken, not stirred: mechanical stress testing of an IgG1 antibody.

Authors:  Sylvia Kiese; Astrid Papppenberger; Wolfgang Friess; Hanns-Christian Mahler
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

5.  Aggregation-prone motifs in human immunoglobulin G.

Authors:  Naresh Chennamsetty; Bernhard Helk; Vladimir Voynov; Veysel Kayser; Bernhardt L Trout
Journal:  J Mol Biol       Date:  2009-06-13       Impact factor: 5.469

6.  Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products.

Authors:  John F Carpenter; Theodore W Randolph; Wim Jiskoot; Daan J A Crommelin; C Russell Middaugh; Gerhard Winter
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

7.  Evaluation of Hofmeister effects on the kinetic stability of proteins.

Authors:  James M Broering; Andreas S Bommarius
Journal:  J Phys Chem B       Date:  2005-11-03       Impact factor: 2.991

8.  Conformational origin of the aggregation of recombinant human factor VIII.

Authors:  A O Grillo; K L Edwards; R S Kashi; K M Shipley; L Hu; M J Besman; C R Middaugh
Journal:  Biochemistry       Date:  2001-01-16       Impact factor: 3.162

9.  Kinetics and thermodynamics of dimer formation and dissociation for a recombinant humanized monoclonal antibody to vascular endothelial growth factor.

Authors:  J M Moore; T W Patapoff; M E Cromwell
Journal:  Biochemistry       Date:  1999-10-19       Impact factor: 3.162

10.  Effect of ions on agitation- and temperature-induced aggregation reactions of antibodies.

Authors:  R Matthew Fesinmeyer; Sabine Hogan; Atul Saluja; Stephen R Brych; Eva Kras; Linda O Narhi; David N Brems; Yatin R Gokarn
Journal:  Pharm Res       Date:  2008-12-23       Impact factor: 4.200

View more
  15 in total

1.  Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.

Authors:  Paolo Arosio; Simonetta Rima; Massimo Morbidelli
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

2.  Aggregation and chemical modification of monoclonal antibodies under upstream processing conditions.

Authors:  Stefan Dengl; Marc Wehmer; Friederike Hesse; Florian Lipsmeier; Oliver Popp; Kurt Lang
Journal:  Pharm Res       Date:  2013-01-16       Impact factor: 4.200

3.  Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs.

Authors:  Friederike Plath; Philippe Ringler; Alexandra Graff-Meyer; Henning Stahlberg; Matthias E Lauer; Arne C Rufer; Melissa A Graewert; Dmitri Svergun; Gerald Gellermann; Christof Finkler; Jan O Stracke; Atanas Koulov; Volker Schnaible
Journal:  MAbs       Date:  2016-03-31       Impact factor: 5.857

4.  Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.

Authors:  A Singla; R Bansal; Varsha Joshi; Anurag S Rathore
Journal:  AAPS J       Date:  2016-02-22       Impact factor: 4.009

5.  Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study.

Authors:  Neh Nupur; Nidhi Chhabra; Rozaleen Dash; Anurag S Rathore
Journal:  MAbs       Date:  2017-12-07       Impact factor: 5.857

6.  Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody Therapeutics.

Authors:  Sahithi Ravuluri; Rohit Bansal; Nidhi Chhabra; Anurag S Rathore
Journal:  Pharm Res       Date:  2018-05-14       Impact factor: 4.200

Review 7.  Conformational stability and self-association equilibrium in biologics.

Authors:  Benjamin R Clarkson; Arne Schön; Ernesto Freire
Journal:  Drug Discov Today       Date:  2015-11-19       Impact factor: 7.851

8.  Formation of multimeric antibodies for self-delivery of active monomers.

Authors:  Yaron Dekel; Yossy Machluf; Tal Gefen; Gennady Eidelshtein; Alexander Kotlyar; Yaron Bram; Ehud Shahar; Farah Reslane; Elina Aizenshtein; Jacob Pitcovski
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  In vitro aggregation behavior of a non-amyloidogenic λ light chain dimer deriving from U266 multiple myeloma cells.

Authors:  Paolo Arosio; Marta Owczarz; Thomas Müller-Späth; Paola Rognoni; Marten Beeg; Hua Wu; Mario Salmona; Massimo Morbidelli
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

10.  Synthesis of Disulfide-Bridging Trehalose Polymers for Antibody and Fab Conjugation Using a Bis-Sulfone ATRP Initiator.

Authors:  Neil L Forsythe; Heather D Maynard
Journal:  Polym Chem       Date:  2021-02-11       Impact factor: 5.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.